Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia
NCT: NCT06996834 · RECRUITING
Brief Summary
This randomized controlled trial aims to compare the efficacy and safety of high-velocity nasal insufflation (HVNI) versus standard noninvasive ventilation (NIV) in adult patients experiencing acute exacerbations of community-acquired pneumonia (CAP) accompanied by hypoxemic respiratory failure. The primary focus is on assessing treatment failure within 48 hours, defined as the need for intubation or death. Secondary outcomes include evaluations of gas exchange parameters, patient comfort levels, duration of ICU stay, and 28-day mortality rates.
Frequently Asked Questions
What is Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia?
Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia is a clinical trial registered under NCT06996834. Current status: RECRUITING.
What is the status of NCT06996834?
The current status of NCT06996834 (Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia) is: RECRUITING.
When did Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia start?
Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia started on 2025-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.